BSE/vCJD agents propagate with little or no transmission barrier in transgenic mice expressing the ovine ARQ PrP [33], [52], [53] and can be passaged in those expressing the ovine VRQ PrP variant (tg338 mice) [54]. This evidence concerns the gene PRNP and variant Creutzfeldt-Jakob disease.